Table 4 |
||||||
|
LSIL incidence among women with normal cytology followed upbetween March 2003 and December 2006 in Kampala, Uganda |
||||||
|
HPV type |
No. of women |
Person years |
Incident LSIL |
Incidence rate per 100 p. yrs |
Crude RR (95% CI)a Infected/non-infected |
p-value |
|
|
||||||
|
HPV 16 |
||||||
|
|
||||||
|
Non-infected |
142 |
114 |
21 |
18.4 |
1 |
|
|
Infected |
8 |
9 |
1 |
11.1 |
0.5 (0.1 -- 3.9) |
0.52 |
|
|
||||||
|
HPV 18 |
||||||
|
|
||||||
|
Non-infected |
147 |
120 |
21 |
17.5 |
1 |
|
|
Infected |
3 |
3 |
1 |
33.3 |
2.2 (0.3 -- 16.2) |
0.45 |
|
|
||||||
|
High-risk HPV types |
||||||
|
|
||||||
|
Non-infected |
104 |
81 |
12 |
14.8 |
1 |
|
|
Infected |
46 |
43 |
10 |
23.3 |
1.4 (0.6 -- 3.4) |
0.39 |
|
|
||||||
|
Low-risk HPV types |
||||||
|
|
||||||
|
Non-infected |
122 |
99 |
20 |
20.2 |
1 |
|
|
Infected |
28 |
24 |
2 |
8.3 |
0.4 (0.1 -- 1.8) |
0.25 |
|
|
||||||
|
HPV 16-related b |
||||||
|
|
||||||
|
Non-infected |
124 |
98 |
18 |
18.4 |
1 |
|
|
Infected |
26 |
25 |
4 |
16 |
0.8 (0.3 -- 2.3) |
0.64 |
|
|
||||||
|
HPV 18-related c |
||||||
|
|
||||||
|
Non-infected |
142 |
117 |
19 |
16.2 |
1 |
|
|
Infected |
8 |
64 |
3 |
50 |
3.5 (1.0 -- 11.8) |
0.05 |
|
|
||||||
|
Any HPV type |
||||||
|
|
||||||
|
Non-infected |
76 |
58 |
10 |
17.2 |
1 |
|
|
Infected |
74 |
65 |
12 |
18.5 |
1.0 (0.4 -- 2.5) |
0.91 |
|
|
||||||
|
Abbreviations: CI, confidence intervals; p. yrs, person--years aFurther adjusted for age, HIV, lifetime number of sexual partners did not change the results bIncludes HPV 16, 31, 33, 35, 52 and 58 cIncludes HPV 18, 39, 45, 59 and 68 |
||||||
|
Banura et al. Infectious Agents and Cancer 2010 5:7 doi:10.1186/1750-9378-5-7 |
||||||
